Teresa Wynn Roseborough
Known title: EVP, Gen. Counsel & Corp. Sec.CIK: 0001534511
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Hartford Closes Equitable Benefits Deal, Faces Lower Price Targets. The Hartford has completed its acquisition of Equitable’s employee benefits business, aiming to strengthen that segment. Following the deal, several analysts, including Keefe, Bruyette & Woods and Wells Fargo, lowered their price targets. The stock is currently trading near its 52-week high, with a P/E ratio of 8.3.
Transaction History
| HD | ▼ Sell | Open Market | 2,455 | $807K | 8/28/2026 | View on chart |
| HIG | ▲ Buy | Grant | 1,356 | $190K | 7/27/2026 | View on chart |
| HD | ▲ Buy | Grant | 2,440 | $0 | 3/25/2026 | View on chart |
| HD | ▲ Buy | Grant | 2,519 | $0 | 2/26/2026 | View on chart |
| HD | ▼ Sell | Tax Withholding | 1,059 | $397K | 2/26/2026 | View on chart |
| HD | ▼ Sell | Tax Withholding | 665 | $249K | 2/26/2026 | View on chart |
| HD | ▼ Sell | Open Market | 2,608 | $909K | 12/26/2025 | View on chart |
| HD | ▼ Sell | Open Market | 264 | $92K | 12/26/2025 | View on chart |
| HD | ▲ Buy | Option Exercise | 2,524 | $459K | 8/22/2025 | View on chart |
| HD | ▲ Buy | Option Exercise | 1,579 | $462K | 8/22/2025 | View on chart |
| HD | ▼ Sell | Open Market | 4,103 | $1.7M | 8/22/2025 | View on chart |
| HD | ▼ Sell | Open Market | 1,380 | $570K | 8/22/2025 | View on chart |
| HIG | ▲ Buy | Grant | 1,525 | $190K | 7/30/2025 | View on chart |
| HD | ▼ Sell | Open Market | 5,406 | $2.0M | 5/28/2025 | View on chart |
| HD | ▲ Buy | Grant | 2,240 | $0 | 3/26/2025 | View on chart |
| HD | ▲ Buy | Grant | 576 | $0 | 2/27/2025 | View on chart |
| HD | ▼ Sell | Tax Withholding | 246 | $96K | 2/27/2025 | View on chart |
| HD | ▼ Sell | Tax Withholding | 458 | $179K | 2/26/2025 | View on chart |
| HD | ▲ Buy | Option Exercise | 7,571 | $1.4M | 11/14/2024 | View on chart |
| HD | ▲ Buy | Option Exercise | 3,157 | $924K | 11/14/2024 | View on chart |
| HD | ▲ Buy | Option Exercise | 1,384 | $439K | 11/14/2024 | View on chart |
| HD | ▼ Sell | Open Market | 12,635 | $5.2M | 11/14/2024 | View on chart |
| HD | ▼ Sell | Open Market | 5,149 | $2.1M | 11/14/2024 | View on chart |
| HD | ▼ Sell | Open Market | 4,300 | $1.8M | 11/14/2024 | View on chart |
| HD | ▲ Buy | Option Exercise | 9,972 | $1.9M | 11/14/2024 | View on chart |
| HD | ▼ Sell | Open Market | 5,195 | $1.9M | 8/15/2024 | View on chart |
| HIG | ▲ Buy | Grant | 1,726 | $190K | 7/29/2024 | View on chart |
| HD | ▲ Buy | Grant | 1,525 | $0 | 3/20/2024 | View on chart |
| HD | ▼ Sell | Tax Withholding | 2,964 | $1.1M | 2/22/2024 | View on chart |
| HD | ▲ Buy | Grant | 6,571 | $0 | 2/22/2024 | View on chart |
| HD | ▼ Sell | Tax Withholding | 910 | $338K | 2/22/2024 | View on chart |
| HD | ▲ Buy | Option Exercise | 3,000 | $568K | 2/21/2024 | View on chart |
| HD | ▼ Sell | Open Market | 10,866 | $3.9M | 2/21/2024 | View on chart |
| HD | ▼ Sell | Open Market | 1,469 | $534K | 2/21/2024 | View on chart |
| HD | ▲ Buy | Option Exercise | 4,032 | $594K | 2/21/2024 | View on chart |
| HD | ▲ Buy | Option Exercise | 10,866 | $1.9M | 2/21/2024 | View on chart |
| HD | ▼ Sell | Open Market | 4,032 | $1.5M | 2/21/2024 | View on chart |
| HD | ▼ Sell | Open Market | 3,000 | $1.1M | 2/21/2024 | View on chart |
| HD | ▼ Sell | Open Market | 6,091 | $2.0M | 8/22/2023 | View on chart |
| HIG | ▲ Buy | Grant | 2,504 | $180K | 7/31/2023 | View on chart |
| HD | ▲ Buy | Grant | 2,016 | $0 | 3/22/2023 | View on chart |
| HD | ▲ Buy | Grant | 10,540 | $0 | 2/22/2023 | View on chart |
| HD | ▼ Sell | Tax Withholding | 4,517 | $1.3M | 2/22/2023 | View on chart |
| HD | ▼ Sell | Tax Withholding | 549 | $163K | 2/22/2023 | View on chart |
| HD | ▼ Sell | Open Market | 5,000 | $1.6M | 11/16/2022 | View on chart |
| HIG | ▲ Buy | Grant | 2,838 | $180K | 8/1/2022 | View on chart |
| HD | ▲ Buy | Grant | 1,797 | $0 | 3/23/2022 | View on chart |
| HD | ▼ Sell | Tax Withholding | 3,553 | $1.1M | 2/24/2022 | View on chart |
| HD | ▼ Sell | Tax Withholding | 832 | $261K | 2/24/2022 | View on chart |
| HD | ▲ Buy | Grant | 8,928 | $0 | 2/24/2022 | View on chart |
| HD | ▼ Sell | Open Market | 3,298 | $1.3M | 11/17/2021 | View on chart |
| HD | ▼ Sell | Open Market | 3,433 | $1.4M | 11/17/2021 | View on chart |
| HD | ▼ Sell | Open Market | 6,300 | $2.5M | 11/17/2021 | View on chart |
| HD | ▼ Sell | Open Market | 2,505 | $989K | 11/17/2021 | View on chart |
| HD | ▼ Sell | Open Market | 977 | $385K | 11/17/2021 | View on chart |
| HD | ▲ Buy | Option Exercise | 6,785 | $884K | 11/17/2021 | View on chart |
| HD | ▲ Buy | Option Exercise | 12,093 | $1.8M | 11/17/2021 | View on chart |
| HD | ▼ Sell | Open Market | 300 | $120K | 11/17/2021 | View on chart |
| HD | ▼ Sell | Open Market | 2,065 | $822K | 11/17/2021 | View on chart |
| HD | ▼ Sell | Open Market | 5,000 | $1.6M | 8/23/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Home Depot Faces Scrutiny on Sales Momentum and Store Growth
Recent analyst coverage focuses on whether Home Depot's sales momentum supports its current valuation, with specific attention to the impact of flat store sales. Investors are also rotating into consumer stocks like Home Depot from tech, potentially providing a lift. The company's outlook may shift based on upcoming catalysts, while technical signals show a Bollinger Band breakout and recent support rejection.
Home Depot Faces Scrutiny on Sales Momentum and Store Growth. Recent analyst coverage focuses on whether Home Depot's sales momentum supports its current valuation, with specific attention to the impact of flat store sales. Investors are also rotating into consumer stocks like Home Depot from tech, potentially providing a lift. The company's outlook may shift based on upcoming catalysts, while technical signals show a Bollinger Band breakout and recent support rejection.